Estefania Mendez-Alvarez

发表

A simple method for isolating rat brain mitochondria with high metabolic activity: Effects of EDTA and EGTA

A. Beiras-Iglesias, S. Sánchez-Iglesias, J. Iglesias-González, 2013, Journal of Neuroscience Methods.

Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases.

P. Carrupt, Alessandra Nurisso, N. Denora, 2015, Journal of medicinal chemistry.

Copper increases the ability of 6‐hydroxydopamine to generate oxidative stress and the ability of ascorbate and glutathione to potentiate this effect: potential implications in Parkinson's disease

R. Soto-Otero, A. Cruces-Sande, E. Mendez-Alvarez, 2017, Journal of neurochemistry.

2‐Benzazepine Nitrones Protect Dopaminergic Neurons against 6‐Hydroxydopamine‐Induced Oxidative Toxicity

A. V. Varlamov, V. P. Zaytsev, M. de Candia, 2012, Archiv der Pharmazie.

Differential Toxicity of 6-Hydroxydopamine in SH-SY5Y Human Neuroblastoma Cells and Rat Brain Mitochondria: Protective Role of Catalase and Superoxide Dismutase

P. Jenner, S. Rose, S. Sánchez-Iglesias, 2012, Neurochemical Research.

Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions

Á. Hermida-Ameijeiras, S. Sánchez-Iglesias, R. Soto-Otero, 2004, Neurochemistry International.

Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson's disease.

J. Labandeira-Garcia, Á. Hermida-Ameijeiras, R. Soto-Otero, 2002, Biochimica et biophysica acta.

Effect of iron and manganese on hydroxyl radical production by 6-hydroxydopamine: mediation of antioxidants.

J. Labandeira-Garcia, Á. Hermida-Ameijeiras, R. Soto-Otero, 2001, Free radical biology & medicine.

Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease.

Ramón Soto-Otero, Estefanía Méndez-Alvarez, J. Labandeira-Garcia, 2002, Biochemical pharmacology.

Effects of Aluminium on Rat Brain Mitochondria Bioenergetics: an In vitro and In vivo Study

A. Beiras-Iglesias, S. Sánchez-Iglesias, J. Iglesias-González, 2015, Molecular Neurobiology.

Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants.

R. Soto-Otero, I. Sánchez-Sellero, E. Mendez-Alvarez, 2011, Journal of pharmacological and toxicological methods.

Ester derivatives of annulated tetrahydroazocines: a new class of selective acetylcholinesterase inhibitors.

A. V. Varlamov, M. de Candia, M. Catto, 2006, Bioorganic & medicinal chemistry.

Autoxidation and Neurotoxicity of 6‐Hydroxydopamine in the Presence of Some Antioxidants

J. Labandeira-Garcia, Á. Hermida-Ameijeiras, R. Soto-Otero, 2000, Journal of neurochemistry.

Time-Course of Brain Oxidative Damage Caused by Intrastriatal Administration of 6-Hydroxydopamine in a Rat Model of Parkinson’s Disease

J. Labandeira-Garcia, S. Sánchez-Iglesias, R. Soto-Otero, 2006, Neurochemical Research.

A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins.

Lourdes Santana, Humberto González-Díaz, Eugenio Uriarte, 2006, Journal of medicinal chemistry.

Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine- and 1,2,4-triazine-containing tricyclic derivatives.

B. Testa, F. Leonetti, M. Catto, 2007, Journal of medicinal chemistry.